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Background: There are several studies that have shown an increased risk of premature birth and developmental
abnormalities with in vitro fertilization (IVF); however, the data on preterm mortality and morbidity are limited.
Aim: Our aim is to investigate whether IVF had an effect on the mortality and morbidity in neonates admitted to
the neonatal intensive care unit.
Methods: A total of 940 term and preterm babies who were admitted to the intensive care unit over a period of
2 years were enrolled. Of these, 121 babies were born after IVF and 810 were born after a natural conception and
9 were born after ovulation induction. Of these, 112 preterm babies were born after IVF and 405 preterm babies
were born after a natural conception.
Results: In the IVF group, the gestational age and birth weight were significantly lower than in the non-IVF group.
Additionally, in the IVF group, multiple births were significantly higher than in the non-IVF group. IVF pregnancies
increase preterm delivery but did not increase preterm mortality, and preterm morbidity did not differ among
groups, except for intraventricular hemorrhage (IVH). Gestational age was shown to be the primary risk factor for
IVH using a logistic regression analysis. Also when newborns at gestational age <32 weeks were compared using
regression analysis, gestational age was the major risk factor for IVH.
Conclusion: IVF appears to be associated with premature delivery and the known risks associated with prematurity.Introduction
Assisted reproductive technique rates are increasing world-
wide. Parallel to the rise in assisted reproductive technique
rates, publications that demonstrate intrauterine growth
retardation, premature birth, perinatal mortality, very low
birth weight, and congenital anomalies as contributing fac-
tors for poor perinatal outcomes have also increased [1-7].
The mortality of premature infants has decreased in our
country and in neonatal intensive care units (preterm
mortality 5%) over the past decades; yet, our country still
has higher mortality than other developed countries [8,9].
In particular, multiple gestations are increased after in vitro
fertilization (IVF) [10-12]. The risk for low-birth-weight
and very-low-birth-weight infants or adverse perinatal
outcomes is increased in singletons and multiples after IVF
when compared to natural conception [13-15].* Correspondence: gulcanturker@kocaeli.edu.tr
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reproduction in any medium, provided the orStudies that have investigated the effects of IVF on
neonatal mortality and morbidity are increasing recently.
However, studies on the outcome of preterm infants,
especially very-low-birth-weight infants, after IVF are
limited. In this study, we aimed to study whether IVF
had an effect on the mortality and morbidity in neonates
admitted to the neonatal intensive care unit.
Methods
Study population
The University Hospital is the only referral center in this
region with a 20-bed critical care neonatal unit and an
IVF center. Thus, many high-risk pregnancies (including
fetuses with cardiac defects) are referred to this obstetric
department, and nearly 50% of these newborns are hospi-
talized. All of the newborns treated in the neonatal inten-
sive care unit between 2009 and 2010 were included in this
study. There were 121 infants born after IVF pregnancies
including intracytoplasmatic sperm injection, 9 infants
born after ovulation induction and 810 infants born after
naturally conceived pregnancies. After the 9 infants withtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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931 newborns were finally studied.
Data Collection
All medical records were retrospectively collected
through specially designed. These data were entered into
a computerized relational database. For each newborn,
the basic demographic information, biological data, and
clinical outcomes (diagnosed or suspected) during the
observation period were recorded. The local ethical
committee gave approval to the study.
Preterm infants were defined as a gestational age
below 37 weeks.
Small for gestational age was defined as a birth weight
below the 10th percentile.
Patent ductus arteriosus (PDA): The occurrence of
hemodynamic PDA was defined according to echocar-
diographic criteria (left atrial to aortic root ratio >1.5,
pulsed Doppler signal within the duct and ductal diam-
eter >1.5 mm in the first 30 hours after delivery, pulsa-
tile transductal flow (Vmax) <1.8 m/sec, reverse end-
diastolic flow in the descending aorta/mesenteric artery)
and/or clinical signs and symptoms of significant left-to
-right ductal shunting, such as an active precordium,
bounding pulses, wide pulse pressure, and systemic
hypotension. According to our neonatal intensive care
unit standards, preterm infants at gestational age <32 -
weeks had screening echocardiograms for PDA between
days one and four of life routinely. Indomethacin or
ibuprofen infusion was given to preterm newborns if
clinical symptoms were present and if the echocardio-
graphic criteria for hemodynamic PDA were met.
Intraventricular hemorrhage (IVH): Cranial sonograms
were performed routinely, daily in the first week of life
and weekly thereafter until hospital discharge, or more
frequently if clinically indicated for all preterm new-
borns. IVH was classified from grade I to IV according
to the grading system of Papile et al.
Bronchopulmonary dysplasia (BPD): The classic diagno-
sis of BPD was identified as oxygen dependency at 36 weeks
post-conception age.
Retinopathy of prematurity (ROP): An ophthalmologic
examination was performed in the fourth week of life. It
was repeated every two weeks by the same examiners.
After pupillary dilatation, indirect ophthalmoscopy
was performed. Fundoscopic findings were recorded
in accordance with the International Classification of
ROP. Examinations were repeated until the retina was
completely vascularized or until the retinopathy was
stable for at least 3 months.
Necrotizing enterocolitis (NEC): Necrotizing enterocoli-
tis was diagnosed according to Bell’s classification stage >2.
Sepsis: Sepsis was dignosed when positive blood culture
and CRP.Criteria for rescue treatment of respiratory distress syn-
drome (RDS): Early rescue treatment with a surfactant
was given to preterm infants with respiratory distress who
required continuous nasal positive pressure or assisted
ventilation and did not present with radiological evidence
of another disease process.
Life-threatening congenital anomalies are chromo-
somal abnormalities (trisomy 13, 18), renal agenesis,
pulmonary hypoplasia, diaphragm hernia and the other
major malformations.
Statistical analysis
For many variables in the collected data, the standard
deviations were wide and the distributions were not nor-
mal. Therefore, a statistical analysis was performed using
medians and ranges. Differences between groups were
analyzed using the Mann–Whitney U test or the chi-
squared test. Risk factors of mortality were evaluated
with binary logistic regression analysis in all preterms.
Independent risk factors of mortality in all of the new-
borns were IVF, gestational age, SGA, preterm prema-
ture rupture of membranes (pPROM), preeclampsia,
Apgar score at 5 minutes, duration of surfactant adminis-
tration, congenital anomalies (non-life-threatening or
life-threatening) and multiple gestations. The risk fac-
tors for morbidity, including the administration of sur-
factant, need of mechanic ventilation, PDA and IVH, were
evaluated with a binary logistic regression analysis only in
preterm newborns. The independent risk factors of surfac-
tant, the need of mechanic ventilation, PDA and IVH were
IVF, gestational age, SGA, preterm premature rupture of
fetal membranes (pPROM), preeclampsia, Apgar score at
5 minutes, duration of surfactant administration and mul-
tiple gestations. Additionally, the risk factors of IVH in
newborns at gestational age <32 weeks were evaluated
using a binary logistic regression analysis. Independent risk
factors of IVH in newborns at gestational age <32 weeks
were IVF, gestational age, multiple gestations and ante-
natal steroid administration. The variables were studied as
independent risk factors in logistic regression analyses and
were significantly different in the IVF group when com-
pared to the non-IVF group.
Statistical analyses were performed using the Statistical
Package for Social Sciences for Windows (SPSS, Inc.,
Chicago, Illinois, USA). Statistical significance was defined
as a p-value < 0.05.
Results
The distributions of the study population according to
the gestational age at birth and the order of gestation
are shown in Table 1.
In vitro fertilization cases were compared to non-IVF
cases for prenatal findings preterm newborns (Table 2). In
the IVF group, gestational age and birth weight were
Table 1 Morbidity and mortality of preterm infants after in vitro fertilization (IVF) and after natural conception (non-IVF)
Variable IVF group n =112 Non-IVF group n =405 p-value
*Maternal age 30 (23–39) 28 (16–46) <0.001
*Gravidity 2 (1–3) 2 (1–6) <0.001
**Preeclampsia 16 (14) 81 (20) 0.2
Male/female (n) 50/62 252/153 0.2
**Intrauterine growth retardation 7 (6) 51 (13) 0.1
**Cesarean section 93 (83) 326 (80) 0.015
**Meconium-stained amniotic fluid 1 (1) 5 (1) 0.7
**Preterm premature rupture of fetal membranes 15 (13) 63 (16) 0.8
**Outborn newborn 6 (5) 42 (10) 0.1
**No prenatal maternal management 3 (3) 19 (5) 0.1
**Antenatal steroid 73 (18) 96 (24) <0.001
*Gestational age (week) 31 (23–36) 32 (22–36) <0.001
*Birth weight (g) 1770 (480–4060) 1980 (380–4200) <0.001
**Multiple birth
Twins 57 (51) 56 (14) <0.001
Triplets 30 (27) 10 (3)
Quadruplets - 1
**Necessitating mechanical ventilation at admission 48 (43) 109 (27) <0.001
**Respiratory distress syndrome 48 (43) 117 (29) 0.005
**Bronchopulmonary dysplasia 16 (13) 36 (9) <0.001
**Intraventricular hemorrhage <0.001
Grade 1 14 (13) 36 (9)
Grade 2 7 (6) 12 (3)
Grade 3 4 (4) 4 (1)
Grade 4 3 (3) 3 (1)
**Patent ductus arteriosus 19 (17) 42 (10)
Ligation 2 1
Ibuprofen treatment 10 14 <0.001
Indomethacin treatment 6 14
**Necrotizing enterocolitis
Grade 1 11 (10) 34 (9)
Grade 2 7 (6) 21 (5) 0.001
Grade 3 2 (1)
** Retinopathy of prematurity
Grade 1 6 (5) 5 (1) 0.073
Grade 2 2 (2) 8 (7)
Grade 3 2 (2) 4 (1)
**Sepsis
Early 28 (25) 64 (16) 0.052
Late 12 (11) 37 (9)
*Hospitalization time 9 (0–97) 8 (0–97) 0.064
**Mortality 7 (6) 36 (9) 0.2
* Results are presented as median (minimum-maximum).
** Results are presented as number and percentage, n (%).
p < 0.05 is statistically significant. *Mann–Whitney U test or **chi-squared test was used.
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Independent variables P value OR (%95CI) P value OR (%95CI) P value OR (%95CI) P value OR (%95CI)
Constant <0.001 <0.001 <0.001 <0.001
IVF 0.2 1.02 (0.6-1.6) 0.023 2.1 (1.1-4.2) 0.12 2.02 (0.83-4.91) 0.21 1.65 (0.75-3.63)
Gestational age <0.001 0.76 (0.68-0.82) 0.005 0.87 (0.81-0.94) <0.001 0.67 (0.6-0.73) <0.001 0.72 (0.65-0.79)
SGA 0.30 0.6 (1.2-1.5) 0.63 0.9 (0.4-1.92) 0.62 1.2 (0.49-3.14) 0.062 2.1 (0.97-4.8).
pPROM 0.71 087 (0.42-1.81) 0.81 1.07 (0.58-1.97) 0.31 0.66 (0.29-1.51) 0.41 0.75 (0.36-1.5)
Preeclampsia 0.1 0.76 (0.45-1.2) 0.86 0.95 (0.6-1.98) 0.23 1.6 (0.8-3.1) 0.057 0.44 (0.2-0.99)
5-minute Apgar score 0.81 1.04 (0.98-1.1) 0.011 0.93 (0.88-0.98) 0.35 1.03 (0.9-1.12) 0.67 1.02 (0.95-1.09)
Duration of surfactant administration <0.001 1.08 (1.05-1.11) 0.31 1.01 (0.98-1.03) 0.095 1.02 (1.004-1.05)
Multiple gestation 0.33 0.7 (0.4-138) 0.4 0.82 (0.51-13) 0.45 0.67 (0.3-1.5) 0.66 1.2 (0.5-2.2)
Binary (enter) logistic regression analysis was used.
Dependent variable: surfactant administration, necessitating mechanical ventilation, PDA, IVH.
Independent variables: IVF, gestational age, SGA, pPROM, preclampcia, Apgar score at 5 minutes, duration of surfactant administration, multiple gestations.
IVF, in vitro fertilization; IVH, intraventricular hemorrhage; pPROM, preterm premature rupture of membrane; SGA, small for gestational age.
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in the IVF group, multiple births, cesarean section and
antenatal steroid administration were significantly higher
than in the non-IVF group (p < 0.05) (Table 1). In the non-
IVF group, the number of out born newborns and the lack
of or poor prenatal maternal management was signifi-
cantly higher than in the IVF group. Compared to the
IVF group, non-life-threatening and life-threatening
congenital anomalies were significantly higher in the
non-IVF group. The incidence of non-life-threatening con-
genital heart disease in the non-IVF group was not different
from the IVF group. In the preterm IVF subgroup, respira-
tory distress syndrome, PDA and IVH were also signifi-
cantly higher than in the non-IVF preterm subgroup (p <
0.05) (Table 1). Early or late neonatal sepsis, BPD, NEC
ROP, hospitalization time and mortality in preterm infants
born after IVF were not different from those in the non-
IVF group (Table 1). When newborns at gestational age
<32 weeks were compared, only multiple birth and IVH
were significantly higher in the IVF subgroup when com-
pared to the preterm non-IVF subgroup (Table 3). In only
preterm infants; using a binary logistic regression analysis,
gestational age, the 5-minute Apgar score and congenital
anomalies (non-life-threatening and life-threatening) were
found to affect mortality. IVF has no impact on newborn
mortality especially preterm mortality and morbidity
(Table 2 and 4). In only preterm newborns gestational age
predicted the requirement for surfactant replacement
therapy, whereas IVF, gestational age, and late surfactant
replacement therapy predicted the need for mechanical
ventilation at admission with binary logistic regression
analysis (Table 2). Only gestational age had an effect on
PDA and IVH in the same logistic regression analysis
(Table 2). Multiple pregnancies and PROM did not have
effects on mortality, the incidence of PDA or IVH, or theneed for surfactant replacement therapy and mechanical
ventilation (Table 2).
When newborns at gestational age <32 weeks were
compared using a binary logistic regression analysis,
gestational age was the only risk factor for IVH (Table 5).
Multiple gestations and antenatal steroid administration
did not have effects on IVH in this subgroup of preterm
newborns (Table 5).
Discussion
In accordance with the literature, premature births
and multiple births were common among IVF preg-
nancies in our study. In the multicenter study of the
Turkish Neonatal Society, the frequencies of neonatal
intensive care unit admissions, PDA, IVH, surfactant
administration and mechanical ventilation were higher in
infants born after assisted reproductive techniques, in-
cluding IVF [15]. However, unlike previous studies, IVF
had no effect on mortality and morbidity in our study,
despite an increased risk of preterm births and multiple
births [14-24]. When newborns at gestational age <32 -
weeks were compared, only multiple births and IVH were
significantly higher in the IVF subgroup compared to the
non-IVF preterm subgroup. However, only gestational age
was a risk factor for IVH using the logistic regression
analysis; IVF was not. Additionally, in some recently
published studies, there no effects were reported on
short-term mortality and morbidity in preterm infants
after IVF [25-27].
In vitro fertilization had no effect on the incidence of
PDA and IVH, surfactant and mechanical ventilation
requirements, BPD, or ROP. Similar to infants conceived
naturally, the major risk factor for morbidity in prema-
ture babies was early gestational age. Multiple pregnan-
cies are also known to increase the morbidity in
Table 3 Characteristics of the in vitro fertilization (IVF) and non-IVF premature newborns with gestational
age <32 weeks
Variable IVF group n =40 Non-IVF group n =113 p value
*Maternal agec 28 (20–43) 29 (20–36) 0.001
*Gravidity 1 1 (1–6) 0.024
**Preeclampsia 9 (23) 28 (25) 0.7
Male/female (n) 22/18 62/51 0.9
**Multiple birth
Twins 20 (50) 13 (12) <0.001
Triplets 10 (25) 3 (2.7) <0.001
*Gestational age (weeks) 28 (22–31) 29 (23–31) 0.034
*Birth weight (grams) 1180 (550–2350) 1100 (380–2370) 0.2
**Intrauterine growth retardation 1 (3) 16 (14) 0.028
**Cesarean section 32 (80) 85 (75) 0.54
**Preterm premature rupture of fetal membranes 13 (33) 23 (20) 0.12
**Out born newborn 2 (5) 13 (12) 0.23
**No or prenatal maternal management 40 (100) 106 (94) 0.27
**Antenatal steroid 28 (70) 74 (36) 0.002
**Doppler 3 (8) 21 (19) 0.24
**Resuscitation 10 (25) 29 (26) 0.8
**Oligohydramnios 9 (23) 24 (21) 0.86
**Congenital anomaly, non-life-threatening/ life-threatening 1/0 (3) 6/0 (5) 0.67
**Congenital heart anomaly 4 (10) 6 (5) 0.32
*1-minute Apgar score (0–10) (1–9) 0.6
*5-minute Apgar score (0–10) (1–9) 0.9
**Respiratory distress syndrome 33 (83) 84 (79) 0.05
**Bronchopulmonary dysplasia 16 (40) 28 (25) 0.068
**ROP
Grade 1 6 (15) 5 (4) 0.1
Grade 2 2 (5) 6 (5)
Grade 3 2 (5) 3 (3)
**Intraventricular hemorrhage
Grade 1 11(28) 21 (19) <0.001
Grade 2 7 (18) 7 (6)
Grade 3 4 (10) 3 (3)
Grade 4 3 (8) 3 (3)
* Results are presented as median (minimum-maximum).
** Results are presented as number and percentage, n (%).
p < 0.05 is statistically significant. *Mann–Whitney U test or **chi-squared test was used.
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to IVF, multiple pregnancies were not associated with
mortality and morbidity in this study. Congenital ano-
malies, particularly imprinting-type single mutations, are
more common in IVF. In this study, the increased rates
of congenital anomalies, particularly cardiac anomalies,
in the non-IVF group were remarkable. In our region,
due to the poor or absent prenatal follow-up in mothers
who conceived naturally than prenatal follow-up inmothers who conceived using IVF, the increased rate of
congenital anomalies in the mothers who conceived nat-
urally may be misinterpreted. Also antenatal screening
for congenital anomalies has reduced congenital anoma-
lies through termination of pregnancy in IVF pregna-
ncies. But in pregnancies with natural conception our
countries that have not introduced the use of prenatal
diagnostic techniques and access to termination of preg-
nancy because of congenital anomaly have seen large
Table 4 Risk factors for mortality in all preterm
Mortality
Independent variables P value OR (%95CI)
IVF 0.08 0.33 (0.09-1.17)
Gestational age <0.001 0.71 (0.63-0.80)
SGA 0.4 0.6 (0.15-2.3)
pPROM 0.2 1.6 (0.6-3.9)
Preeclampsia 0.2 0.38 (0.1-1.9)
5-minute Apgar score 0.006 0.84 (0.76-0.93)
Duration of surfactant administration 0.2 1.01 (0.98-1.04)
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countries with more restrictive policies on pregnancy
termination. Therefore it is difficult to interpret the effects
of IVF on the incidence of congenital anomalies because
only the infants in the intensive care unit were studied.
Similarly, the results of the actual incidence of premature
birth or factors related to premature birth in IVF pregnan-
cies may be misleading. The predominance of premature
newborns among IVF babies in the intensive care unit
was notable, in particular, extreme prematurity (birth
before 29 weeks gestation) [28]. The prognosis for these
very preterm infants is poor, and there is a very low chance
of intact survival if born before 26 weeks [20]. The
risk of cerebral palsy in twins has been estimated to
be four times that of singletons, and even moderate
prematurity is associated with long-term educational
and behavioral problems and infant death [20,29-32].
Several studies have demonstrated that premature birth
and congenital anomaly rates were increased in IVF preg-
nancies when compared to naturally conceived pregnancies
[3-14]. However, recent publications did not report an in-
crease in preterm births or SGA [27]. In this study by
Messerschmid et al., multiple pregnancies and IVF did not
have effects on preterm mortality and morbidity, as in our
study [27]. They found only that the initial venous pH value
was higher (7.25 vs 7.23) in multiples with weights betweenTable 5 Risk factors of intraventricular hemorrhage (IVH)
in premature newborns with gestational age <32 weeks
IVH
Independent variables P values OR (%95CI)
IVF 0.054 2.58 (0.98-6.82)
Gestational age <0.014 0.81 (0.68-0.95)
Multiple gestations 0.12 1.65 (0.98-6.82)
Antenatal steroid 0.57 1.07 (0.83-1.37)
Binary (enter) logistic regression analysis was used.
Dependent variable: IVH.
IVF, in vitro fertilization; IVH, intraventricular hemorrhage.1000–1499 g after IVF than naturally conceived infants.
They suggested that this small difference does not appear
to be relevant from a clinical standpoint [27]. We observed
a higher rate of multiples after IVF than after natural con-
ception, as in their study. Additionally, we did not assess
the number of monozygotic multiples, as in their study.
According to the results of 15 different national obstetrics
centers, mortality is approximately 15% in twin pregnan-
cies, at least in one of the twin pairs. The perinatal mortal-
ity ratio is 107 per thousand. Discordant females born
before the 30th gestational week have the highest
mortality risk [33]. Both morbidity and mortality are
known to be higher in monozygotic twins compared
to dizygotic twins [13]. Therefore, Messerschmid
et al. concluded that they expect the outcome of mul-
tiples after IVF to be better than in multiples after
natural conception [27]. However, we may suggest
that the cause of the similar morbidity and mortality
rates after IVF and natural conception is related to
advanced therapeutic measures in newborn intensive care
units because we found that multiple pregnancies were
not a risk factor for increased mortality and morbidity.
There are several limitations to this study, including
the small sample size of premature newborns born before
32 weeks of gestation. However, IVH was significantly
higher in the IVF subgroup than the non-IVF preterm
subgroup when newborns at gestational age <32 weeks
were compared. It is difficult to adjust for IVH in the IVF
group because multiple births are more common in the
IVF group. However, when newborns at gestational
age <32 weeks were compared using a regression analysis,
only gestational age was found to be a risk factor for IVH.
Therefore, we conclude that gestational age has an effect
on IVF. Two or three eggs are fertilized in each treatment
in our IVF center. Therefore, if one egg is fertilized in each
treatment in our center, we may decrease the rate of
premature birth and IVH.
The main drawback of our study is that the study
population did not include the general population; it
only included the babies in the intensive care unit.
Therefore, the factors of infertility and its effects on
preterm births and anomalies were not investigated.
In the light of these studies and the similar data that
we obtained, studies that investigate the effects of
antenatal follow-up and the major factors of infertility
on mortality and morbidity are required rather than
studies on the use of IVF methods. Finally, these conclu-
sions can be reached only by appropriately designed and
powered randomized studies.
Conclusion
On the basis of our study, we conclude that IVF appears
to be associated with premature delivery and the known
risks associated with prematurity.
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